Delaware Health and Social Services (DHSS) is implementing a Preferred Drug List (PDL) and Supplemental Rebate Program for the Delaware Medical Assistance Program (DMAP). DHSS has retained Provider Synergies and the Medicaid fiscal agent, EDS, to provide PDL management and supplemental rebate contracting services.
As part of the state's effort to control costs and provide clinically sound drug therapy for recipients, Provider Synergies will support the DMAP Pharmacy and Therapeutics Committee (P&T) and DHSS in the expansion of the selection of preferred medications. This expansion will be based on a review of the relative clinical effectiveness and cost of products within selected therapeutic classes. The program's objective is to achieve quality pharmaceutical care for recipients enrolled in the Department's Medicaid programs while providing significant state savings.
Provider Synergies provides expert clinical staffing and services to Delaware Medicaid including support of the P&T Committee, PDL development and ongoing management, supplemental rebate negotiation and comprehensive reporting services.
Participation in the Supplemental Rebate Process for Delaware Medicaid
This state is now participating in the TOP$℠ program.
Once your company has provided contact information to Provider Synergies, your company's designated representatives will be notified when one or more of your products are under consideration for the PDL.
For questions about the PDL, please e-mail PSDelawarePDLQuestions@magellanhealth.com.